Nutex Health, Inc.NUTXNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +25.62% | +269.77% | +213.98% | +220.69% | +239.87% |
| Gross Profit Growth | +85.54% | +971.84% | +1065.07% | +453.71% | +606.68% |
| EBITDA Growth | +600.30% | +0.00% | +772.59% | +156.89% | +1628.98% |
| Operating Income Growth | +0.00% | +0.00% | +4881.30% | +535.57% | +1249.17% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +15.03% | +26.78% | +22.64% | +10.90% | +31.40% |
| Weighted Average Shares Diluted Growth | +15.03% | +20.98% | +27.37% | +17.66% | +40.74% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +244.93% | +0.00% | +1570.44% | +460.02% | +1365.71% |
| Free Cash Flow Growth | +0.00% | +0.00% | +2095.90% | +484.65% | +1507.37% |
| Receivables Growth | +21.30% | +276.02% | +355.29% | +435.32% | +483.91% |
| Inventory Growth | -15.79% | -15.95% | +4.79% | -17.56% | +39.79% |
| Asset Growth | -8.58% | +64.55% | +88.46% | +99.11% | +119.96% |
| Book Value per Share Growth | -41.57% | +87.83% | +155.04% | +384.20% | +299.37% |
| Debt Growth | -7.47% | +23.40% | +25.32% | +9.81% | +18.26% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +50.80% | +200.20% | +15.24% | +18.00% | -4.50% |